All lobbying filings

Miller Strategies, LLC

Miller Strategies, LLC filed a Q3 report for Pfizer Inc. on October 20, 2026, reporting $150,000 in lobbying income.

Lobbying for Pfizer Inc. · pharmaceutical corporation

As filed: MILLER STRATEGIES, LLC for PFIZER INC.

All filings by Miller Strategies, LLC · Everything Pfizer Inc. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$150,000

What the client paid this registrant for the period.

Client based in

New York

Official filing document

Government bodies contacted 1

Executive Office of the President (EOP)

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 4

Medicare/Medicaid

Medicare and healthcare policy issues as they relate to drug pricing.

Health Issues

Issues related to 340B Program

Taxation/Internal Revenue Code

General issues with tax reform and foreign tax issues.

Labor Issues/Antitrust/Workplace

Issues related to drug consolidation.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.